Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia

被引：0
|
作者：
Yoji Ishida
Kazunori Murai
Kohei Yamaguchi
Takuto Miyagishima
Motohiro Shindo
Kazuei Ogawa
Takahiro Nagashima
Shinji Sato
Reiko Watanabe
Satoshi Yamamoto
Takayuki Hirose
Souich Saitou
Masakatsu Yonezumi
Takeshi Kondo
Yuichi Kato
Noboru Mochizuki
Keiko Ohno
Satoshi Kishino
Kohmei Kubo
Tatsuo Oyake
Shigeki Ito
机构：
[1] Iwate Medical University School of Medicine,Saitama Medical Center
[2] Aomori Prefectural Central Hospital,Department of Hematology and Oncology, Internal Medicine
[3] Kushiro Rosai Hospital,undefined
[4] Asahikawa Medical University School of Medicine,undefined
[5] Fukushima Medical University School of Medicine,undefined
[6] Kitami Red Cross Hospital,undefined
[7] Okitama Public General Hospital,undefined
[8] Saitama Medical University,undefined
[9] Sapporo City General Hospital,undefined
[10] Niigata Cancer Center Hospital,undefined
[11] Nihonkai General Hospital,undefined
[12] Hokkaido Cancer Center,undefined
[13] Hokkaido University School of Medicine,undefined
[14] Yamagata University Faculty of Medicine,undefined
[15] Meiji Pharmaceutical University,undefined
[16] Iwate Medical University School of Medicine,undefined
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Dasatinib; Phamacokinetics; Pharmacodynamics; Molecular response; Half maximal inhibitory concentration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：185 / 193
页数：8
相关论文
共 50 条
  • [31] Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease
    Mori, Jinichi
    Oshima, Kumi
    Tanimoto, Tetsuya
    Ishizuka, Hikari
    Kimura, Shinya
    Miura, Masatomo
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 115 - 117
  • [32] Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease
    Jinichi Mori
    Kumi Oshima
    Tetsuya Tanimoto
    Hikari Ishizuka
    Shinya Kimura
    Masatomo Miura
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 115 - 117
  • [33] Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients
    Peng, B
    Hayes, M
    Resta, D
    Racine-Poon, A
    Druker, BJ
    Talpaz, M
    Sawyers, CL
    Rosamilia, M
    Ford, J
    Lloyd, P
    Capdeville, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 935 - 942
  • [34] DASATINIB OR IMATINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTES IN THE CHRONIC PHASE: FIVE-YEARS FOLLOW-UP SIMULATED COHORT
    Darba, J.
    Perez-Alvarez, N.
    Kaskens, L.
    Martin, P.
    VALUE IN HEALTH, 2011, 14 (07) : A435 - A436
  • [35] An Observational Prospective Study of Dasatinib 50mg Daily As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia Patients in Chronic Phase
    Singh, Reema
    Halder, Rohan
    Kapoor, Jyotsna
    Verma, Megha
    Mehta, Pallavi
    Agrawal, Narendra
    Ahmed, Rayaz
    Bhurani, Dinesh
    BLOOD, 2022, 140 : 12197 - 12199
  • [36] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Masayuki Hino
    Itaru Matsumura
    Shin Fujisawa
    Kenichi Ishizawa
    Takaaki Ono
    Emiko Sakaida
    Naohiro Sekiguchi
    Yusuke Tanetsugu
    Kei Fukuhara
    Masayuki Ohkura
    Yuichiro Koide
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 24 - 32
  • [37] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Hino, Masayuki
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 24 - 32
  • [38] Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Takahashi, Naoto
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Hino, Masayuki
    BLOOD, 2019, 134
  • [39] DASATINIB IN CHRONIC MYELOID LEUKEMIA
    Modic, Mojca
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I147 - I150
  • [40] Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase
    Michihide Tokuhira
    Yuta Kimura
    Keiji Sugimoto
    Tomonori Nakazato
    Maho Ishikawa
    Isao Fujioka
    Tomoiku Takaku
    Noriyoshi Iriyama
    Eriko Sato
    Hiroyuki Fujita
    Yoshihiro Hatta
    Norio Komatsu
    Norio Asou
    Masahiro Kizaki
    Tatsuya Kawaguchi
    Medical Oncology, 2018, 35
12345